Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Oct 6, 2022--
The "Alzheimer's Disease Diagnostics and Therapeutics Market, By Product and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028" report has been added to ResearchAndMarkets.com's offering.
Alzheimer's disease is a neurodegenerative disease that usually starts slowly and progressively worsens. It is a progressive form of dementia, a continuous decline in thinking, behavioral, and social skills that disrupts a person's ability to function independently. Doctors perform a series of tests to rule out other possible causes of impairment.
It can be diagnosed in several different ways. Imaging techniques, such as CT and MRI, are primarily used to rule out other conditions that may cause symptoms similar to Alzheimer's but require different treatment. There's no cure for Alzheimer's disease, but there are treatments that may change disease progression, and drug and non-drug options that may help treat symptoms. Aducanumab is the only disease-modifying medication currently approved to treat Alzheimer's.
Market Dynamics:
Increasing use of biomarkers in Alzheimer's diagnosis and drug development and increasing focus on the development of novel diagnostics & therapeutics due to increase in disease burden is expected to boost the growth of the global Alzheimer's disease diagnostics and therapeutics market.
For instance, in in June 2021, the Alzheimer's Drug Discovery Foundation (ADDF) Diagnostics Accelerator launched four new research investments for the development of digital biomarkers for Alzheimer's diagnosis.
Moreover, in August 2022, the Alzheimer's Association announced the launch of Alzheimer's Network for Treatment and Diagnostics (ALZ-NET), a platform to collect long-term clinical and safety data from patients treated with FDA-approved Alzheimer's disease therapies in real world clinical settings. It is the first network developed specifically for FDA-approved Alzheimer's treatments, collecting real-world evidence on drug effectiveness and side effects over a long period of time.
Key features of the study:
Detailed Segmentation:
Global Alzheimer's Disease Diagnostics and Therapeutics Market, By Product:
Global Alzheimer's Disease Diagnostics and Therapeutics Market, By Geography:
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/jm78rt
View source version on businesswire.com:https://www.businesswire.com/news/home/20221006005535/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: GENERAL HEALTH NEUROLOGY OTHER HEALTH HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 10/06/2022 06:40 AM/DISC: 10/06/2022 06:41 AM
http://www.businesswire.com/news/home/20221006005535/en